the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Singapore PM defends exclusive deal to lure Taylor Swift

MELBOURNE: Singapore struck a deal ensuring Taylor Swift played the city-state but nowhere else in Southeast Asia, the country’s prime minister said Tuesday while defending the secretive arrangement.

Pop icon Swift is halfway through a run of six sold-out shows in Singapore, the only city in Southeast Asia to feature in her blockbuster Eras world tour.

The star’s schedule has sparked controversy in the music-mad region, with Singapore accused of throwing cash at Swift to stop her from appearing in other locations.

The issue unexpectedly reared its head at the ASEAN-Australia summit in Melbourne — a sober affair typically more preoccupied with matters of security and economic growth.

“Our agencies negotiated an arrangement with her to come to Singapore and perform, and to make Singapore her only stop in Southeast Asia,“ Prime Minister Lee Hsien Loong said at a joint press conference with his Australian counterpart.

“A deal was reached. And so it has turned out to be a very successful arrangement. I don’t see that as being unfriendly.”

Singapore has repeatedly declined to detail the financial terms of the deal.

After Singapore, Swift’s Eras Tour will head to Europe. -AFP

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings